No Flush Niacin 500 mg
80/100
This product is generally safe
- Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
- 50% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
Label Data
1 Tablet(s)
Serving Size
30
Servings
Single Vitamin and Mineral
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
500 mg
(3125% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 14.3× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Calcium
150 mg
(12% DV)
Other Ingredients
Dicalcium Phosphate
Microcrystalline Cellulose
Stearic Acid
Silica
Croscarmellose Sodium
Magnesium Stearate
Hypromellose
Glycerin
Carnauba wax
Talc
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Vegan
Vegetarian
Adult (18 - 50 Years)
Gluten Free
Dairy Free
Sugar Free
Product Information
📋 Directions for Use
Directions: Take 1 tablet daily with food as a dietary supplement or as directed by a healthcare professional.
⚠️ Warnings & Precautions
Keep out of reach of children.
Do not purchase if seal is broken.
🧪 Formulation Notes
Made in the U.S.A. from globally sourced ingredients.
Inositol Hexanicotinate
Promotes heart health Boost healthy circulation
No sugar, wheat, soy, milk, artificial colors, flavors or preservatives Non gmo - gluten free - vegan
Non gmo - gluten free - vegan
Additional Information
Protect from heat, light & moisture. Store in a cool, dry place.
Product Details
UPC / SKU
0 35046 00336 4
DSLD Entry Date
2023-11-22
Product Type
Single Vitamin and Mineral
Form
Tablet or Pill
DSLD ID
299514
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100